C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.430
-0.040 (-1.62%)
At close: Dec 15, 2025, 4:00 PM EST
2.449
+0.019 (0.79%)
After-hours: Dec 15, 2025, 6:57 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $235.5 million as of December 15, 2025. Its market cap has decreased by -20.38% in one year.
Market Cap
235.50M
Enterprise Value
97.21M
1-Year Change
-20.38%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $235.50M, a decrease of -69.52%. That is a compound annual growth rate of -20.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 239.38M | -5.80% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |